Web Content Viewer (JSR 286) 15min

Azioni
Caricamento...

News of the project

Project updates

Return to work in Head and Neck cancer patients and Quality of life: insights from literature

A recent review was published with the aim of determining the prevalence of return to work (RTW) amongst head and neck cancer (HNC) survivors and to determine its impact on quality of life (QoL), providing some interesting results.

UPM attended the 46th IEE EMBS international conference

UPM participated in the ‘Digital Oncology: supporting clinical trials with biomedical sensors and wearables in cancer treatment and post-cancer follow up’ leading this mini symposium, within the 46th annual IEE EMBS international conference

27th July Is the Head and Neck Cancer day

World Head and Neck Cancer Day is held on 27 July each year. It’s an opportunity to raise awareness about head and neck cancer in the general public and acknowledge the impact it has on people affected in our communities.

BD4QoL predictive model

The main goal of machine learning models in healthcare is to accurately estimate patient risk. For a model to be practical, it should not only have good discriminative performance but also be well-calibrated so that the predicted probabilities are meaningful and interpretable. So model development starts by defining the right probability to be estimated.

Università degli Studi di Bari recruiting activities started

Università degli Studi di Bari, newly introduced member of the BD4QoL Consortium, has just started the patients’ recruiting activities. So far they’ve enrolled 15 people, therefore 309 patients are so far part of the BD4QoL Prospective Clinical Study.

BD4QoL contributes to training Medical Doctors in the deployment and use of digital health technology for supporting patient Quality-of-Life after cancer treatment

Partner MME, co-organized in cooperation with the Association of Medical Doctors of the Province of Parma a Workshop titled “Advancements in Quality-of-Life monitoring after oncology treatment”.

Save the date! 25–31 May is the European Week Against Cancer (EWAC)

The European Week Against Cancer (EWAC) is an international awareness initiative, held annually from 25 to 31 May, which aims at joining forces in Europe in the fight against cancer and inspire action against it. EWAC 2024 will focus on different specific themes like, for example, “digital health & care”, “research”, “patients and survivors”.

DOTSOFT Excels at BEYOND Expo with a Focus on Enhancing Healthcare through Big Data

DOTSOFT successfully participated in the recent BEYOND Expo , one of the foremost technology and innovation events in Europe. Held annually, BEYOND Expo draws industry leaders, innovators, and technology enthusiasts to explore the latest advancements and emerging trends in the tech world.

Birmingham partners close to reaching target

The University of Birmingham and University Hospitals Birmingham NHS Trust in the UK have recruited 19 of 20 patients into the BD4QoL study. They are hoping to reach their milestone by the end of May 2024.

BD4QoL presented to Physicians in Parma event

BD4QoL project has been presented on March 19th, 2024 at an event organised by Physicians in Parma, Italy.

Europe’s Beating Cancer Plan: the importance of initiatives to improve the quality of life of cancer patients and survivors

On 31 January 2024, the Europe's Beating Cancer Plan conference took place in Brussels. The Plan is one of the funding pillars of the European Health Union and focuses, among other, on improving the quality of life of cancer patients and survivors.

World cancer day 2024

February 4th is the World Cancer Day. Survivorship care in an unmet need. The EU BD4QoL project aims to tackle the QoL deterioration of head and neck cancer survivors through smartphone-based non-obtrusive monitoring.

BD4QoL Expands Patient Enrollment, Overcomes Challenges, and Advances Mobile App Usage with DOTSOFT Support

In a significant milestone for the groundbreaking European project BD4QoL, the consortium proudly announces a substantial increase in patient enrollment from partner clinical sites. This surge underscores the growing impact of BD4QoL in reshaping post-treatment experiences for individuals who have overcome head and neck cancer.

How digital technologies are changing the way in which evidence is generated in Medicine

Through its involvement in BD4QoL, CSS partner has gained valuable insights into how emerging digital technologies can impact the generation of evidence in medicine. The traditional gold standard for demonstrating the safety and efficacy of a clinical intervention, particularly when involving drug administration, has been the principles of Evidence-Based Medicine (EBM).

INT - UMIL attending the Health & Tech Summit 2023

INT - UMIL partners are going to present at the Health & Tech Summit 2023 the technological solutions developed and used in the prospectic clinical study for remote monitoring H&N patients QoL. The conference updates on topics such as AI, Big data and cutting-edge technologies in the healthcare sector.

Participating in the BD4QoL project can represent a sign of hope for patients to return to a normal life

During the follow-up visits scheduled in the BD4QoL project, the CSS team has observed that some enrolled patients, upon completing treatments, have managed to return to a lifestyle close to normalcy and resume work, albeit with limitations due to changes they had to make in their lifestyle due to the illness.

Embracing the Future of Health: Following the steps of BD4QoL

In a world where personalized well-being takes center stage, BD4QoL pioneers a groundbreaking approach for those navigating life after Head and Neck Cancer treatment. Imagine a future where wearables and personal devices seamlessly intertwine with Big Data-driven AI algorithms, fostering real-time monitoring and support for individual Quality of Life (QoL).

BD4QoL attending the FAITH project networking event “AI in Healthcare”

BD4QoL attended the networking event “AI in Healthcare”, dedicated to artificial intelligence in the healthcare domain. How should artificial intelligence (AI) applications be introduced in the healthcare domain? What are the challenges faced so far, and what has been overlooked?

Ensuring privacy and access to data in the BD4QoL project

The aim of the European project BD4QoL is to improve the quality of life of people who have overcome a head or neck cancer, through individual monitoring and follow-up of patients. In order to carry out this task successfully, daily data on the activities and habits of the participants are collected through mobile applications, which allow the development of personalized interventions on individuals during treatment to prevent risks and avoid negative effects derived from the disease.

Point of Care tool training session with healthcare professionals

As the BD4QoL medical team grows and the latest updates are incorporated into the clinical dashboard, the Point of Care tool, the past 23rd of October took place a Training Session between technical partners and clinicians.

Lombardy Region and ARIA holding a workshop with patients' associations

On October 17th, Lombardy Region and ARIA are holding a workshop with patients' associations in order to present the digital solutions developed in BD4QoL. More stakeholders will attend the meeting such as service providers, BD4QoL Partners, patients involved in the projects, policy makers and clinicians.

HTA analysis for D6.1 predictive models

The BD4QoL Deliverable D6.1 Benchmark risk stratification models, has produced interesting models that can predict Health Related Quality of Life (HRQoL) trajectories, based on demographic and clinical variables.

BD4QoL Poster within CHIGreece23 Conference

DOTSOFT attended the CHI Greece 2023 Conference: an esteemed gathering of visionaries in the realm of Human-Computer Interaction (HCI) bore witness to the emergence of the BD4QoL project, a project of innovation and hope.

11th head & neck cancer awareness week

September marks head & neck cancer awareness week.

Experience on patient engagement from CSS

A personal patient report on his experience in BD4QoL enrolment

Inequalities in returning to work after H&N cancer

Starting from a cohort of residents in Turin (Piedmont, Italy) from 2008 to 2018 it was possible to select 255 incident cases of H&N cancer related to workers in the year of diagnosis, who had no cancer in other sites in the considered period. Within this subset, about 34% of patients didn’t work during the two years after the diagnosis.

Save the Date! BD4QoL workshop with patients’ associations: 17 October 2023

Lombardy Region and ARIA, partners of the BD4QoL project, are organizing a workshop with patients’ associations, which will take place online on October 17th, 2023, from 9:45 am to 1pm.

What is the BD4QoL historical cohort?

The BD4QoL project focuses on studying the quality of life of people who have survived head and neck cancer. But what does it mean to be a survivor? What are the characteristics of these survivors?

Maternity beyond disease

Favouring maternity beyond diseases that once used to be considered as an obstacle to parenthood: this is an important project taking place in Lombardy at the IRCCS San Matteo in pavia along with local university.

Measuring behaviour for patient self-empowerment: Android vs iOS platforms

One of the results of the BD4QoL market analysis has been the appreciation of differences existing among the two major mobile OS platforms – iOS and Android – when it comes to behaviour measurement, which is needed to implement several mHealth applications that target patient empowerment and self-care.

Dissemination of BD4QoL project scope and results within the scientific event held in Ioannina, Greece about Smart-Health

A scientific event on SMART HEALTH was held in Ioannina on May 26, 2023. This project focuses on developing an expert system for automating the diagnosis of learning and communication disabilities in children.

CSS presented BD4QoL in two Italian workshops

Two relevant events for the general public and for the community of H&N surgeons hosted talks on BD4QoL in Italy

BD4QoL attended CS_AIW meeting

BD4QoL participated in the CS_AIW meeting (Cancer Survivorship – AI for Well-being) held in Madrid.

Using Latent Class Analysis to define profiles of H&N cancer patients

SEPI partner started to exploit the new occupational dataset, which was built as a product of the project.

Data security and privacy

On April 7, the International Health Day was celebrated. Personal data relating to health are considered as a special category and therefore specially protected. At the BD4QoL project, we are aware of the importance of treating the most sensitive data correctly.

A new study from Lombardy to surgically treat inoperable tumors

Policlinico di Milano, Vimercate Hospital and Ancona Hospital are united against cancer in a study related to tumours regarded as inoperable.

MME contributes to BD4QoL Market Study

MME formulated two specific elements of the BD4QoL Market Study: the outline of the value proposition and the identification of the addressable market segments.

DOTSOFT demonstrate the mobile app in the 16th EAI International Conference on Pervasive Computing Technologies for Healthcare

DOTSOFT participated in the 16th EAI International Conference on Pervasive Computing Technologies for Healthcare that took place between 12-14 December 2022 in Thessaloniki, Greece

BD4QoL prospective clinical trial: updates from “Casa Sollievo della Sofferenza” pilot site

The enrollment phase of the BD4QoL project is continuing at “Casa Sollievo della Sofferenza” hospital in S. Giovanni Rotondo, Italy.

UPM will participate in the 16th EAI International Conference on Pervasive Computing Technologies for Healthcare

UPM will participate in the 16th EAI International Conference on Pervasive Computing Technologies for Healthcare where it will present the work done in the context of the BD4QoL project

“Return to work after cancer: scientific evidence and experiences – WAVE-TRAPEZIO project ”

The project partner SEPI will present a study on he difficulty in returning to work and the decline in career prospects for cancer patients.

Fostering innovation in care pathways for cancer patients

ARIA has organized a X-eHealth Hackathon for Rare Diseases and Cancers with the goal of showcasing the state-of-the-art of AI applications in the Rare Diseases and Cancers management domain.

Lombardy Region awarded as a 4 stars Active and Healthy Ageing Reference Site

Lombardy Region has been awarded as a 4 stars Active and Healthy Ageing Reference Site, BD4QoL specifically addresses issues such as active and healthy ageing for HNC treated people, using Big Data.

INETUM in the BD4QoL project: AI in the fight against head and neck cancer

INETUM is carrying out the maintenance of the infrastructure, such as the project documentation portal

MAFEIP: a tool for assessing the cost-effectiveness of the BD4QoL solution

To assess the cost effectiveness of the solutions developed by the Project, the BD4QoL Consortium has selected to use the MAFEIP tool.

BD4QoLhas been accepted for Poster presentation at the ESMO Congress 2022.

BD4QoL has been accepted for Poster presentation (display) at the ESMO Congress 2022 which itook place in Paris from September 9th to 13th, 2022.

Quality rules set to evaluate the mHealth BD4QoL mobile app

The BD4QoL mobile app has been used for more than three months from patients that have survived from Head and Neck Cancer, in the scope of a clinical trial. A set of rigorous and appropriate criteria have been chosen and quality rules automatically generate related clinical trial evaluation results. The process of evaluating the health app is ongoing and a full set of results is expected in the next 24 months.

BD4QoL prospective clinical trial: updates from “Casa Sollievo della Sofferenza” pilot site

The enrollment phase of the BD4QoL project is continuing at “Casa Sollievo della Sofferenza” hospital in S. Giovanni Rotondo, Italy.

Point of care tool update

The Point of Care tool of the BD4QoL project has been updated with new technical features

Results of Horizon Results Booster published

The results of the Horizon Results Booster Module A, describing the main exploitable results of participating projects has been delivered to the Cluster participants and to the European Commission.

Oral presentation at the XLVI conference of the Italian Association of Epidemiology (AIE)

The SEPI team presented in the XLVI AIE conference a work with the aim of studying the impact of having an Head and Neck Cancer (HNSCC) on the weekly wage of employees in Italy.

Digital transformation for integrated and person-centred care and QoL

Lombardy Region and ARIA S.p.A are directly involved in Bd4QoL, Jadecare and HsMonitor innovation projects where digital transformation is addressed to deliver integrated and person-centred care and to improve QoL.

World Head and Neck Cancer Day 2022

The World Head and Neck Cancer Day is held on 27 July each year. It’s an opportunity to raise awareness about head and neck cancer in the general public and acknowledge the impact it has on people affected in our community.

Novel technologies for improving the Quality of Life

Lombardy Region and ARIA S.p.A believe that novel technologies can have an important role for improving the Quality of Life and are actively involved in Bd4QoL, SMART-BEAR and Hocare2.0 innovation projects.

Technology supported counselling for cancer survivors.

Inetum contributes to the BD4QoL project from two different perspectives, from a technical one, with the design and provision of a secure and interoperable data lake equipped with cutting-edge big data technologies and operations.

The Bidi chatbot is recognised by the European Commission’s Innovation radar project

The Innovation Radar is a European Commission initiative that aims to identify and highlight Innovations with high potential from EU funded research projects. The Bidi chatbot, which provides a natural language interface for HNC survivors to ask questions, get health tips and report symptoms to their point of care was highlighted by the Innovation Radar.

BD4QoL partner DOTSOFT was awarded the Silver prize in the BOUSSIAS Cloud Computing Awards!

BD4QoL partner DOTSOFT was awarded the Silver prize in the BOUSSIAS Cloud Computing Awards for the Best Cloud Solution Provider in the Industry of Healthcare!

BD4QoL prospective clinical trial: patient enrollment started in “Casa Sollievo della Sofferenza” hospital

The “Casa Sollievo della Sofferenza” hospital (S. Giovanni Rotondo, Italy) started the enrolment of the patients who participate in the prospective trial for the use of the BD4QoL platform starting from April 11th, 2022.

BD4QoL access to EU-funded Horizon Results Booster (HRB) services

BD4QoL will partner with the EU-funded H2020 project CAPABLE in sharing results and recommendations for the successful dissemination of new Artificial Intelligence assisted technologies for cancer patients quality of life monitoring and support.

BD4QoL has been invited to join the "Cancer Survivorship-AI for well-being cluster"

The initiative, promoted by EU funded project FAITH, will boost the adoption of best practices of participatory research in Artificial Intelligence for healthcare and well-being for the benefit of EU citizens.

First results for the BD4QoL semantic-location based point of interest identification mechanism published

A paper from the BD4QoL partner DEUSTO “Location Based Indoor and Outdoor Lightweight Activity Recognition System” has been published in the Electronics Journal, including the first results for the BD4QoL semantic-location based point of interest identification mechanism.

BD4QoL mentioned during the IAG-KHT Spring Symposium “Head and neck tumours in the focus of health services research”!

The BD4QoL project has been mentioned during the IAG-KHT Spring Symposium “Head and neck tumours in the focus of health services research” organised by the German Cancer Society Interdisciplinary Group on head and neck cancer and held on April 27th, 2022, at the Berlin VKU Congress center.

BD4QoL Project is online on the AIOM website!

The Clinical Study carried out in the context of the BD4QoL Project - Multicentre randomised clinical trial to assess quality of life using non-invasive electronic devices during post-curative follow-up for head and neck cancers – is now online on the AIOM (Associazione Italiana di Oncologia Medica) website!

Highlighting innovations: the BD4QoL project in the European Commission's Innovation Radar!

The innovation “BD4QoL Point of Care (PoC) support tool for healthcare professionals following up Head and Neck Cancer (HNC) survivors” developed in the project has been selected by the European Commission's Innovation Radar

Users' training on the BD4QoL apps

On 25 October 2021, the “Users' training on the BD4QoL apps” was held in Milan

2021 ESMO AWARDS - recognising excellence in oncology

Precision oncology is the goal today, not a simple slogan Prof. Lisa Licitra: “Truly pursuing precision medicine means pushing the boundaries of patient selection using molecular biology and artificial intelligence on all big data, not just molecular information”

Oral presentation at EMBS2020

Abstract: The cancer-related mortality is decreasing in recent times bringing the number of people living with cancer is increased. In this sense, ICT could support clinicians in the follow-up of cancer patients are essential. This paper presents the outcomes from the scoping review of PoC existing solutions.

Poster presentation at ESMO2020 conference.

Paper title: Research and contextual inquiry on information and communication technologies point of care systems for cancer follow-up. This work presents the outcomes from a research work conducted for Point of Care (PoC) systems applied in cancer follow-up.

Web Content Viewer (JSR 286) 15min

Azioni
Caricamento...